Ghasempour Monireh, Khorrami-Nejad Masoud, Akbari Mohamad Reza, Amiri Mohamad Aghazadeh
Department of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Science, Tehran, Iran.
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Science, Tehran, Iran.
J Curr Ophthalmol. 2018 Sep 29;31(2):201-205. doi: 10.1016/j.joco.2018.09.003. eCollection 2019 Jun.
To evaluate the effect of full-time and part-time occlusion therapy on axial length (AL) of non-amblyopic eyes in anisohyperopic patients.
Sixty-five patients who were treated for anisohyperopic amblyopia were recruited for this prospective cross-sectional study. Treatment was provided as patching of the non-amblyopic for 4 h or less (part-time occlusion therapy, n = 42), patching of the non-amblyopic for 8 h or more (full-time occlusion therapy, n = 13) and refractive correction (spectacles, non-patched group, n = 10). AL measurements were calculated by a Lenstar LS 900 at the last session of amblyopia therapy.
The mean age of patients treated for anisohyperopic amblyopia was 4.90 ± 0.80 years, and the mean follow-up period was 1.50 ± 0.80 years. The mean of spherical equivalent in amblyopic and non-amblyopic eyes were +3.58 ± 2.26 and +1.84 ± 0.97 diopter (D) before treatment, and +3.21 ± 2.28 and +1.49 ± 0.99 D after treatment, respectively. The mean of spherical equivalent in non-amblyopic eyes before (F = 0.452, df = 2, P = 0.639) and after (F = 0.190, df = 2, P = 0.828) treatment did not have any significant difference between the three groups. The mean AL of amblyopic and non-amblyopic eyes were 22.11 ± 93.0 and 22.68 ± 1.07 mm, respectively. The mean AL of the non-amblyopic eye was significantly higher in the full-time occlusion therapy group when compared to the part-time patch and the non-patched groups ( < 0.001). The mean AL of amblyopic eyes showed no difference across the three treatment groups ( = 0.840).
The results show that a longer AL in the non-amblyopic eye, but not the amblyopic eye, can be expected with longer daily hours of patching in anisohyperopic patients. Future studies are needed to evaluate the effect of patching on AL in children with anisohyperopic amblyopia.
评估全职和兼职遮盖疗法对屈光参差性远视患者非弱视眼眼轴长度(AL)的影响。
招募65例接受屈光参差性弱视治疗的患者进行这项前瞻性横断面研究。治疗方式为遮盖非弱视眼4小时或更短时间(兼职遮盖疗法,n = 42)、遮盖非弱视眼8小时或更长时间(全职遮盖疗法,n = 13)以及屈光矫正(眼镜,未遮盖组,n = 10)。在弱视治疗的最后阶段,使用Lenstar LS 900计算眼轴长度测量值。
接受屈光参差性弱视治疗的患者平均年龄为4.90±0.80岁,平均随访期为1.50±0.80年。治疗前弱视眼和非弱视眼的等效球镜平均值分别为+3.58±2.26和+1.84±0.97屈光度(D),治疗后分别为+3.21±2.28和+1.49±0.99 D。三组之间非弱视眼前(F = 0.452,自由度 = 2,P = 0.639)后(F = 0.190,自由度 = 2,P = 0.828)等效球镜平均值均无显著差异。弱视眼和非弱视眼的平均眼轴长度分别为22.11±93.0和22.68±1.07毫米。与兼职遮盖组和未遮盖组相比,全职遮盖疗法组非弱视眼的平均眼轴长度显著更高(<0.001)。三个治疗组弱视眼的平均眼轴长度无差异(= 0.840)。
结果表明,屈光参差性远视患者每日遮盖时间越长,非弱视眼而非弱视眼的眼轴长度预计会更长。未来需要开展研究评估遮盖疗法对屈光参差性弱视儿童眼轴长度的影响。